Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

  1. Ugarte, A.
  2. Gil-Bea, F.
  3. García-Barroso, C.
  4. Cedazo-Minguez, A.
  5. Ramírez, M.J.
  6. Franco, R.
  7. García-Osta, A.
  8. Oyarzabal, J.
  9. Cuadrado-Tejedor, M.
Revue:
Neuropathology and Applied Neurobiology

ISSN: 1365-2990 0305-1846

Année de publication: 2015

Volumen: 41

Número: 4

Pages: 471-482

Type: Article

DOI: 10.1111/NAN.12203 GOOGLE SCHOLAR

Objectifs de Développement Durable